Robert E. Leet and Clara Guthrie Patterson Trust Fellowship Program in Clinical Research
The Robert E. Leet and Clara Guthrie Patterson Trust was established in 1980 for the advancement of medical science, particularly research “relating to human diseases, their causes and relief.” The Patterson Trust will provide support to mentored investigators conducting clinical research with a focus on patient-oriented or translational laboratory research. The Program will help the Trust to pursue its mission by providing Applicants with the opportunity to demonstrate creativity and explore opportunities that may promote careers in clinical research. Pilot and preliminary studies are encouraged.
Application Deadline: Friday, August 14, 2015 2:00 p.m., U.S. Eastern Time
ELSA U. PARDEE FOUNDATION
The Elsa U. Pardee Foundation funds research to investigators in United States non-profit institutions proposing research directed toward identifying new treatments or cures for cancer. The Foundation particularly encourages grant applications for a one year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers. It is anticipated that this early stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified. Applications requesting more than 15% overhead are usually not considered. Papers verifying nonprofit status and relevant human subject and experimental animal treatment approvals from the recipient institution will be requested prior to project initiation. A final report summarizing financial expenditure and research achievement is required.
Application Deadline: October 1, 2015
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01)
This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.
Application Due Date: Application Receipt/Submission Date(s): February 17, 2016; August 16, 2016; February 15, 2017; August 15, 2017; February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization.
Yale SPORE in Lung Cancer Career Development Program Award
The goal of the Career Development Program (CDP) of the Yale SPORE in Lung Cancer (YSILC) is to educate the next generation of investigators committed to translational research in lung cancer. The CDP will provide support of up to $50,000 to promising junior investigators and/or establish investigators who have not previously conducted lung cancer focused research. Proposed pilot projects should be innovative and be focused on a broad spectrum of research, and/or technology development applicable to human lung cancer risk, prevention, diagnosis, prognosis, or treatment.
Open to investigators at an academic institution who can be described by one of the following categories: 1) Junior faculty holding appointments 2) Candidates for junior faculty appointments, (e.g., advanced postdoctoral fellows) 3) Established investigators, who are committed to re-focusing a substantial component of her/his research on thoracic oncology and the study of risk prevention, diagnosis, prognosis or treatment of human thoracic malignancies Women and minority investigators are strongly encouraged to apply.
5:00 PM August 14, 2015. LOIs and full applications should be sent by email to Ed Kaftan (Edward.Kaftan@yale.edu
Yale SPORE in Lung Cancer Developmental Research Program Award
To provide seed money to investigators to support studies with a strong translational component that have the potential to evolve into, or be incorporated into, a full Yale SPORE in Lung Cancer (YSILC) project. Projects of more limited scope (e.g., for smaller amounts and/or for shorter periods of time) will be at no competitive disadvantage in the review process. Projects with multi-disciplinary collaborations and promising translational research potential will get favorable scores in review. The purpose is also to generate preliminary data or evidence of collaboration for new NCI grant applications.
Open to investigators who hold a faculty appointment at an academic institution who can be described by one of the following categories:
a) established investigators in lung cancer who wish to test an innovative, translationally-relevant idea not funded by current or pending grants/funds;
b) junior investigators holding a faculty appointment proposing innovative research in the arena of translational thoracic oncology that require preliminary data to apply for an R01 or equivalent research support;
c) independent investigators with a previous and/or current R01 or equivalent funding whose research to date has not been specifically directed at lung cancer, or even at cancer more generally, but who are interested in exploring the applicability of their particular expertise to lung cancer.
Women and minority investigators are strongly encouraged to apply.
: 5:00 PM August 14, 2015. LOIs and full applications should be sent by email to Ed Kaftan (Edward.Kaftan@yale.edu
2015-2016 YALE SPORE IN SKIN CANCER DEVELOPMENTAL RESEARCH AWARDS
The YALE SPORE in Skin Cancer is pleased to announce the availability of DEVELOPMENTAL RESEARCH AWARDS beginning 15 September 2015 to fund projects in amounts up to $50,000 for one year (Projects may be eligible for a second year of funding, pending receipt and review of a competitive renewal application that documents unequivocal progress during the first year of funding.) Developmental Research Program Awards are intended to support a broad spectrum of innovative pilot projects applicable to human skin cancer risk, prevention, diagnosis, prognosis, or treatment. To be funded, DRP projects must have promising translational research potential, i.e., direct application to human skin cancer, and there must be the expectation that they can evolve into, or be incorporated into, full projects with an unequivocal translational component funded either within this SPORE or as independent R01 (or equivalent) grants.
Categories of eligible investigators:
a) Established investigators (with previous and/or current R01 or equivalent funding) whose research to date has not been specifically directed at skin cancer, or even at cancer more generally, but who are interested in exploring the applicability of their expertise to skin cancer;
b) Established investigators in skin cancer who wish to test an innovative, translationally
relevant idea clearly distinct from current or pending grants;
c) Junior investigators (holding a faculty appointment higher than that of Postdoctoral Fellow or Research Associate) without current or past R01 (or equivalent) research support who are proposing innovative research in the arena of translational cutaneous oncology.
d) Previous recipients (as Principal Investigators) of SPORE DRP funds are generally ineligible to be P.I.s of new DRP projects within 3 years of completion of their previous DRP funding.
Priority will be given to projects that include multidisciplinary collaboration with other Yale investigators (including utilization of SPORE Core Facilities), and/or with investigators at other institutions (including other SPOREs in Skin Cancers).
Deadline: August 25, 2015. Completed applications containing all required components to be emailed Marcus Bosenberg (Marcus.Bosenberg@yale.edu) as a single PDF file.
Yale Cancer Center 2015 Rausch Pilot Research Grant from The Edith P. Rausch Fund of The Community Foundation for Greater New Haven
To provide seed money to members of Yale Cancer Center (YCC) to enable
investigators to engage in innovative cancer research, with the goal of facilitating new research on the fundamental causes of, or an effective cure for, cancer. We anticipate funding two to three pilot grants. Priorities for the pilot grants include studying and/or ameliorating sociodemographic disparities in cancer incidence or outcomes; the prevention and/or treatment of women’s cancers, as well as neighborhood/urban or other community factors that contribute to cancer etiology. Preference will be given to research that has a high likelihood of having a demonstrable community impact in the Greater New Haven area.
YCC members or faculty who have applied for membership are eligible to serve as P.I. Grants are not intended to supplement on-going studies or provide bridge funding. Recipients of a pilot award are eligible to apply for a subsequent one-year funded extension which will be judged in the competition with new applications. A P.I. may submit only a single pilot research grant proposal for this competition. Up to $30,800 for one year commencing October 1, 2015.
Application Deadline: August 13, 2015 at 4PM
Class of ’61 Yale Cancer Research Award
AACR NextGen Grants for Transformative Cancer Research
These three-year grants of $450,000 represent a new AACR funding initiative to stimulate highly innovative research from young investigators. Eligibility is limited to junior faculty who have held a full-time, tenure-track appointment as an assistant professor for no more than three years.
Letter of Intent Deadline: August 10, 2015
Provocative Questions in Cancer with an Underlying HIV Infection (R01)
The purpose of this funding opportunity announcement (FOA) is to advance our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying HIV infection or Acquired Immune Deficiency Syndrome (AIDS) through research directed at addressing one of several proposed "Provocative Questions" (PQs). These PQs are not intended to represent the full range of NCI's priorities in HIV/AIDS-related cancer research. Rather, they are meant to challenge researchers to think about and elucidate specific problems and paradoxes in key areas of AIDS-related cancer research that are deemed important but have not received sufficient attention.
Application Deadline: August 18, 2015
Assay Validation For High Quality Markers For NCI-Supported Clinical Trials
The purpose of this Funding Opportunity Announcement (FOA) is to improve the development and validation of molecular diagnostics for the treatment, control, or prevention of cancer. This FOA includes, but is not limited to, the validation of prognostic, predictive or response markers for treatment and markers for cancer control or prevention trials. Applicants should have an assay that works in human samples and whose importance is well justified for development into a clinical assay. In addition, analytical validation of assays for these markers should be achieved when the application is submitted so that clinical validation may be achieved with little further analytical validation needed. This supplement may be used to support acquisition of specimens from retrospective or prospective studies from NCI-supported or other clinical trials. Clinical laboratory staff, technical and other needs must be an integral part of the application. Assays proposed for this FOA may be used to validate existing assays for use in other cancer clinical trials, observational studies or populations. Projects proposed for this FOA will require multi-disciplinary interaction and collaboration among scientific investigators, clinicians, statisticians and clinical laboratory scientists and staff. This FOA is not intended to support trials that assess the clinical utility of a marker/assay but is intended to develop assays to the point where their clinical utility could be assessed in other trials.
Application Deadline: October 7, 2015
Smoking Cessation within the Context of Lung Cancer Screening
The goal of this Funding Opportunity Announcement (FOA) is to improve the effectiveness and/or implementation of smoking cessation interventions delivered to current smokers who undergo low-dose computed tomography (LDCT) lung cancer screening. The proposed projects must be aimed at determining:
a) the key components and characteristics of an effective smoking cessation intervention delivered in the LDCT setting; and/or
b) characteristics of an implementation strategy to optimally incorporate existing evidence-based smoking cessation intervention(s) into the LDCT setting.
Application Deadline: October 8, 2015
In order to recognize significant accomplishment and continuing outstanding promise in cancer research, Yale Cancer Center is pleased to announce the Class of ’61 Yale Cancer Research Award. This annual award recognizes significant accomplishment in cancer research at Yale University by a young member of the faculty, coupled with the expectation for future outstanding contributions to our understanding of the causes and cures for cancer. The annual award, established through the ongoing generosity of the Yale College Class of 1961, will provide unrestricted funds to support the winner’s cancer research. The initial award will be $50,000. Nominees must be Yale faculty members age 45 or less, whose accomplishments are documented by published papers and awarded grants in any area of cancer research including seminal investigations into basic cancer biology, important translational or clinical studies, or critical population science studies. Nomination guidelines and further information can be obtained from
Deadline for nominations:
August 31, 2015
Patterson Trust Fellowship Program in Clinical Research
The Robert E. Leet and Clara Guthrie Patterson Trust was established in 1980 for the advancement of medical science, particularly research "relating to human diseases, their causes and relief." Two-year fellowships of $90,000 ($45,000 per year) will be awarded to Applicants working in Connecticut or New Jersey.
The Patterson Trust will provide support to early-stage mentored investigators conducting clinical research with a focus on patient-oriented or translational laboratory research. The Program will help the Trust to pursue its mission by providing Applicants with the opportunity to demonstrate creativity and explore opportunities that may promote careers in clinical research. Pilot and preliminary studies are encouraged.
Application Deadline: August 14, 2015
YCC/SCH Grants for Small Projects to Improve Patient Care
Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven are pleased to announce a new program to fund small projects to improve patient care at Smilow Cancer Hospital. Monies for this program have come through our “Closer to Free” fund. Any employee at Smilow Cancer Hospital who develops a small project may apply by submitting an application for review. Projects can range from a patient education program to stress management for staff. In order to be eligible, the employee must be sponsored by a current Cancer Center Member. A listing of active cancer center members is on the web site.
Amount: $2,500 to $5,000 each
Eligibility: Employees of Smilow Cancer Hospital at Yale-New Haven
Sponsorship: Member of Yale Cancer Center
Application: Limited to 3 pages, typed, double spaced; plus budget with justification (3 copies)
- Application sheet: Project Due Date
- Project Description
- Budget Justification
Submit to Renee Gaudette:firstname.lastname@example.org
For questions, contact Dr. Ruth McCorkle by email: email@example.com
Breast Cancer Alliance (BCA) Announces three Grant Opportunities for 2016
The mission of the BCA is to improve survival rates and quality of life for those impacted by breast cancer through prevention, early detection, treatment and cure. To promote these goals, we invest in innovative research, breast surgery fellowships, regional education, dignified support and screening for the underserved.
Exceptional Project Grant:
The Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers whose primary focus is breast cancer to apply for an Exceptional Project Grant. The award recognizes creative, unique, and innovative research and is open to applicants at institutions within a 200-mile radius of Greenwich, CT. This is a one-year grant for a total of $100,000. Prior to submission of a formal grant proposal, the BCA requires a one-page Letter of Intent (LOI) and a separate CV. For 2015 grants, those letters will be due on April 2, 2015. The LOI must include the applicant’s name, job title, and institution at the top of the page, and the applicant’s contact information. The document should state the project title and hypothesis, outline the research aim(s) and methods, and include a brief discussion of the project’s potential impact. The CV can be in the NIH biosketch format and should be no more than four pages long. Applicants will be informed by the first week of May 2015 whether they have been invited to proceed with a formal application. Researchers should coordinate with their institutions, as the BCA will accept a maximum of three LOIs per institution. (Full proposals, if invited, will be due on or before July 24, 2015.)
Young Investigator Grants: Note: No limit on the number of submissions per institution.
To encourage a commitment to breast cancer research, the Breast Cancer Alliance invites clinical doctors and research scientists whose primary focus is breast cancer and who are in the early stages of their careers to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions within a 200-mile radius of Greenwich, CT. This is a two-year grant for a total of $125,000, with half the grant award being paid out each year.
Applicants for 2016 grants much (i) have held a faculty position for no more than four years following the completion of their training, as of February 1, 2015; (ii) have not been a principal investigator on an NIH R01 or equivalent national/international non-mentored award; and (iii) dedicate at least 50% of their work effort to research. This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support. Grant applications are due on or before July 24, 2015. An independent External Review Committee reviews and evaluates the applications. Based on their results and subsequent review by the Grants Committee, recommendations will be made to the BCA Board for final approval. Applicants will be notified in mid-December of the decision regarding their proposals. To download an application, click here: 2016-YIG-application For questions about any research grants, please e-mail: firstname.lastname@example.org
Education and Outreach Grants:
The Breast Cancer Alliance offers grants to support programs directly related to outreach and case managerial breast cancer services, including education, counseling, and mammograms for the uninsured/underserved. The programs must be located in Connecticut and/or Westchester County, New York. This is a one-year grant.
For 2016 grants, final applications are due on or before July 31, 2015. The Grants Committee of the Breast Cancer Alliance reviews and evaluates each grant proposal. The results of the Grants Committee’s evaluations and subsequent recommendations are presented to the BCA Board for approval. Applicants are notified in mid-December of the decision regarding their proposals. To download the final report form for 2014 grants, click here for the 2014 Final Report
For questions about any education and outreach grants please email: email@example.com